| Typicality: | 0.474 |
| Saliency: | 0.261 |
| at 50 to 60 weeks | 4 | temporal |
| with nicotinamide riboside | 2 | other |
| mouse → develop → liver cancer | 5 |
| mouse → develop → liver tumors | 4 |
| mouse → developed → liver cancer | 3 |
| negative | neutral | positive |
| 0.435 | 0.506 | 0.059 |
| Raw frequency | 12 |
| Normalized frequency | 0.261 |
| Modifier score | 0.850 |
| Perplexity | 238.262 |